Spinal Simplicity announced FDA clearance of Freedom DS, a minimally invasive system for lumbar spinal stenosis designed to improve procedural control and efficiency.
OVERLAND PARK, Kan., April 23, 2026 /PRNewswire-PRWeb/ -- today announced FDA clearance of the Freedom Decompression System鈩� (Freedom DS), a minimally invasive solution designed to treat lumbar spinal stenosis through targeted decompression.
The system introduces enhanced instrumentation designed to improve procedural control and efficiency, including integrated depth gauges in each of the bone and tissue tools, optimized angle management, and instrumentation designed to remove more tissue with fewer passes.
Freedom DS expands Spinal Simplicity's portfolio, enabling physicians to treat patients with both percutaneous decompression and indirect decompression with stabilization鈥攕upporting a more complete, patient-specific approach to care.
"Freedom DS was designed with precision and purpose," said , CEO of Spinal Simplicity."Every instrument is thoughtfully engineered to enhance control, helping physicians work more efficiently. Most importantly, this expands our ability to treat the right patient with the right solution, all rooted in our mission to put patients first and help them get their freedom back."
"Advancements in instrumentation matter," said Timothy Deer, MD, Chairman of . "The enhanced design of Freedom DS allows for greater procedural efficiency鈥攅nabling physicians to accomplish more with less motion. That level of control is critical in minimally invasive spine procedures. More importantly, innovations like this push the entire field forward鈥攁nd ultimately benefit patients."
The company will initiate a phased limited market release, beginning with a controlled trial phase, with a full commercial launch expected later in 2026.
About Spinal Simplicity
Spinal Simplicity is a medical device company focused on developing minimally invasive solutions that address the root causes of back and or leg pain. The company partners closely with physicians to design technologies grounded in biomechanics and real-world patient needs, expanding access to effective treatments in the outpatient setting. Through a commitment to innovation, education, and patient-first care, Spinal Simplicity is helping patients get their freedom back.
Media Contact
Parker Snedden, VP of Marketing, Spinal Simplicity, 1 (913) 451-4414, [email protected],
Jonathan Hess, VP of Investor Relations, Spinal Simplicity, 1 (913) 451-4414, [email protected],
SOURCE Spinal Simplicity
Share this article